European Pharmaceutical Review

JULY 25, 2023

A compound annual growth rate (CAGR) growth of 5.9 The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses and rising demand for generic medicines. This is a rise from $162.8 billion in 2022.

Compounding 97

Compounding Generic Medicine Drug Development Diabetes 97

Express Pharma

NOVEMBER 1, 2024

Streamlined regulatory pathways One of the biggest enablers of drug repurposing is the regulatory framework designed to expedite approvals for already-approved compounds. For repurposed drugs, early-stage trials such as Phase 1 or 2 might be sufficient, provided there is existing safety data on the compound,” Vyas explains.

Drug Development 111

Drug Development Compounding Generic Medicine Vaccines 111

Quality Matters

OCTOBER 13, 2021

Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient. There are also related standards that address a wide range of topics such as packaging, storage and distribution of medicines, the preparation of compounded medicines and prescription labeling.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding 52